References
- Adam, S, et al, Wiggins, S, Whyte, P. Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment. Journal of Medical Genetics 1993; 30: 549–556
- Burgess M, Adam S, Bloch M, Hayden M. Dilemmas of anonymous predictive testing for Huntington's disease: privacy vs optimal care. American Journal of Medical Genetics 1997; 71: 197–201
- Craufurd D, Tyler A. Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction Consortium. Journal of Medical Genetics 1992; 29: 915–918
- Gusella, JF, et al, Wexler, NS, Conneally, PM. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306: 234–238
- Handyside AH, Kontogianni EH, Hardy K, Winston RML. Pregnancies from biopsied human preimplantation embryos sexed by Y specific DNA amplification. Nature 1990; 244: 768–770
- Huntington's DiseaseSecond Edition, PS Harper. WB Saunders & Company Limited. 1996
- Harper PS, Lim C, Craufurd D. On behalf of the UK Huntington's Disease Prediction Consortium. Ten years of presymptomatic testing for Huntington's disease: the experience of the Huntington's Disease Prediction Consortium. Journal of Medical Genetics 2000; 37: 567–571
- Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes. Cell 1993; 72: 971–983
- Kiebooms EG, Decruyenaere M. Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals. Patient Education and Counselling 1998; 35: 15–26
- Masood E. UK insurers oppose moratorium plea on use of genetic data. Nature 2000; 391: 3–3
- Quaid K, Morris M. Reluctance to undergo predictive testing: the case of Huntington's disease. American Journal of Medical Genetics 1993; 45: 41–45